Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
There are several interrelated mechanisms involving iron, dopamine, and neuromelanin in
neurons. Neuromelanin accumulates during aging and is the catecholamine-derived …
neurons. Neuromelanin accumulates during aging and is the catecholamine-derived …
Protective and toxic roles of dopamine in Parkinson's disease
The molecular mechanisms causing the loss of dopaminergic neurons containing
neuromelanin in the substantia nigra and responsible for motor symptoms of Parkinson's …
neuromelanin in the substantia nigra and responsible for motor symptoms of Parkinson's …
Structures of the intrinsically disordered Aβ, tau and α-synuclein proteins in aqueous solution from computer simulations
PH Nguyen, P Derreumaux - Biophysical Chemistry, 2020 - Elsevier
Intrinsically disordered proteins (IDPs) play many biological roles in the human proteome
ranging from vesicular transport, signal transduction to neurodegenerative diseases. The Aβ …
ranging from vesicular transport, signal transduction to neurodegenerative diseases. The Aβ …
Impact of dopamine oxidation on dopaminergic neurodegeneration
S Zhang, R Wang, G Wang - ACS chemical neuroscience, 2018 - ACS Publications
Parkinson's disease (PD) is the second most common neurodegenerative disease. The
characteristic feature of PD is the progressive degeneration of the dopaminergic (DAergic) …
characteristic feature of PD is the progressive degeneration of the dopaminergic (DAergic) …
Development of small molecules targeting α-synuclein aggregation: a promising strategy to treat Parkinson's disease
Parkinson's disease, the second most common neurodegenerative disorder worldwide, is
characterized by the accumulation of protein deposits in the dopaminergic neurons. These …
characterized by the accumulation of protein deposits in the dopaminergic neurons. These …
Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease
P Sivakumar, KB Nagashanmugam… - Neurochemistry …, 2023 - Elsevier
Parkinson's disease (PD) is characterized by an abnormal post-translational modifications
(PTM) in amino acid sequence and aggregation of alpha-synuclein (α-Syn) protein. It is …
(PTM) in amino acid sequence and aggregation of alpha-synuclein (α-Syn) protein. It is …
The structural heterogeneity of α-synuclein is governed by several distinct subpopulations with interconversion times slower than milliseconds
Summary α-Synuclein plays an important role in synaptic functions by interacting with
synaptic vesicle membrane, while its oligomers and fibrils are associated with several …
synaptic vesicle membrane, while its oligomers and fibrils are associated with several …
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation
V Oliveri - European journal of medicinal chemistry, 2019 - Elsevier
A host of human diseases, including Parkinson's disease and Dementia with Lewy bodies,
are suspected to be directly linked to protein aggregation. Amyloid protein aggregates and …
are suspected to be directly linked to protein aggregation. Amyloid protein aggregates and …
Opposite structural effects of epigallocatechin-3-gallate and dopamine binding to α-synuclein
A Konijnenberg, S Ranica, J Narkiewicz… - Analytical …, 2016 - ACS Publications
The intrinsically disordered and amyloidogenic protein α-synuclein (AS) has been linked to
several neurodegenerative states, including Parkinson's disease. Here, nanoelectrospray …
several neurodegenerative states, including Parkinson's disease. Here, nanoelectrospray …